X.NOV Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 1

  • Investments
  • 2

X.NOV General Information

Description

Manufacturer of orthopedic medical devices intended for implantable hip and knee orthopedic prostheses. The company specializes in design, manufacturing, marketing and selling orthopedic medical devices for hip and knee surgery, enabling surgeons and healthcare teams to decrease operative times and contribute to the success of hip and knee replacements.

Contact Information

Website
www.xnov.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • ZAC des Guinnottes 2
  • 14 rue du Chêne Sec
  • 70400 Hericourt
  • France
Primary Industry
Therapeutic Devices
Other Industries
Diagnostic Equipment
Vertical(s)
Corporate Office
  • ZAC des Guinnottes 2
  • 14 rue du Chêne Sec
  • 70400 Hericourt
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X.NOV Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore X.NOV‘s full profile, request access.

Request a free trial

X.NOV Patents

X.NOV Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2958534-A1 Femoral part for prosthesis of knee, has trochlea path that forms groove with depth that is increased from anterior edge of end of femoral part to maximum depth point and decreased to end of trochlea part and start of condyle Active 09-Apr-2010
FR-2958534-B1 Female party with troople path with soft flexion. Active 09-Apr-2010
US-8262668-B2 Hip file carrier with a movable jaw Active 30-Jun-2009
US-20100331902-A1 Hip file carrier with a movable jaw Active 30-Jun-2009
FR-2947169-A1 Half ring holder with mobile jaw Active 30-Jun-2009 A61B17/1659
To view X.NOV’s complete patent history, request access »

X.NOV Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X.NOV Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore X.NOV‘s full profile, request access.

Request a free trial

X.NOV Investments (2)

X.NOV’s most recent deal was a Buyout/LBO with Ceraver. The deal was made on 07-Nov-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ceraver 07-Nov-2024 Buyout/LBO Other Devices and Supplies
C2F Implants 01-Dec-2017 Buyout/LBO Surgical Devices
To view X.NOV’s complete investments history, request access »

X.NOV Subsidiaries (1)

Company Name Industry Location Founded
Ceraver Other Devices and Supplies Roissy, France
To view X.NOV’s complete subsidiaries history, request access »

X.NOV FAQs

  • When was X.NOV founded?

    X.NOV was founded in 2003.

  • Where is X.NOV headquartered?

    X.NOV is headquartered in Hericourt, France.

  • What is the size of X.NOV?

    X.NOV has 200 total employees.

  • What industry is X.NOV in?

    X.NOV’s primary industry is Therapeutic Devices.

  • Is X.NOV a private or public company?

    X.NOV is a Private company.

  • What is X.NOV’s current revenue?

    The current revenue for X.NOV is .

  • Who are X.NOV’s investors?

    BFC Croissance and Crédit Mutuel Equity have invested in X.NOV.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »